{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,11]],"date-time":"2026-10-11T07:46:56Z","timestamp":1791704816491,"version":"4.3.4"},"reference-count":31,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,8,9]],"date-time":"2026-08-09T00:00:00Z","timestamp":1786233600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100004607","name":"Guangxi Natural Science Foundation","doi-asserted-by":"publisher","award":["2023JJB140555"],"award-info":[{"award-number":["2023JJB140555"]}],"id":[{"id":"10.13039\/501100004607","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Translational Oncology"],"published-print":{"date-parts":[[2026,11]]},"DOI":"10.1016\/j.tranon.2026.102978","type":"journal-article","created":{"date-parts":[[2026,9,14]],"date-time":"2026-09-14T21:34:34Z","timestamp":1789421674000},"page":"102978","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["11-Oxo-mogroside V attenuates lung adenocarcinoma progression by disrupting metabolic homeostasis and suppressing TGF\u03b22\/Myc-dependent oncogenic signaling"],"prefix":"10.1016","volume":"73","author":[{"given":"Xinyu","family":"Chen","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lihua","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiao","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Liang","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qian","family":"Yu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xuexin","family":"Yan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qianyu","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Haiping","family":"Zheng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jinliang","family":"Kong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qing","family":"Bu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.tranon.2026.102978_bib0001","doi-asserted-by":"crossref","DOI":"10.1016\/j.drup.2024.101057","article-title":"MAFF confers vulnerability to cisplatin-based and ionizing radiation treatments by modulating ferroptosis and cell cycle progression in lung adenocarcinoma","volume":"73","author":"Liang","year":"2024","journal-title":"Drug Resist. Update"},{"issue":"11","key":"10.1016\/j.tranon.2026.102978_bib0002","doi-asserted-by":"crossref","first-page":"1206","DOI":"10.1016\/S1470-2045(23)00444-8","article-title":"Global variations in lung cancer incidence by histological subtype in 2020: a population-based study","volume":"24","author":"Zhang","year":"2023","journal-title":"Lancet Oncol."},{"issue":"2","key":"10.1016\/j.tranon.2026.102978_bib0003","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1016\/S2213-2600(23)00382-X","article-title":"Segmentectomy versus lobectomy in small-sized peripheral non-small-cell lung cancer with radiologically pure-solid appearance in Japan (JCOG0802\/WJOG4607L): a post-hoc supplemental analysis of a multicentre, open-label, phase 3 trial","volume":"12","author":"Hattori","year":"2024","journal-title":"Lancet. Resp. Med."},{"key":"10.1016\/j.tranon.2026.102978_bib0004","doi-asserted-by":"crossref","DOI":"10.1016\/j.neo.2026.101315","article-title":"Molecular landscape and clinical translation of DNA damage response alterations in solid tumors: a pan-cancer perspective on precision oncology","volume":"77","author":"Zhu","year":"2026","journal-title":"Neoplasia"},{"issue":"7","key":"10.1016\/j.tranon.2026.102978_bib0005","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1002\/advs.202409790","article-title":"Pyruvate kinase M2-responsive release of paclitaxel and indoleamine 2,3-dioxygenase inhibitor for immuno-chemotherapy of Nonsmall cell lung cancer","volume":"12","author":"Wu","year":"2025","journal-title":"Adv. Sci."},{"issue":"3","key":"10.1016\/j.tranon.2026.102978_bib0006","doi-asserted-by":"crossref","first-page":"775","DOI":"10.1002\/med.21466","article-title":"Biologically active quinoline and quinazoline alkaloids part I","volume":"38","author":"Shang","year":"2018","journal-title":"Med. Res. Rev."},{"issue":"23","key":"10.1016\/j.tranon.2026.102978_bib0007","doi-asserted-by":"crossref","first-page":"8367","DOI":"10.3390\/molecules27238367","article-title":"Natural products as anticancer agents: current status and future perspectives","volume":"27","author":"Naeem","year":"2022","journal-title":"Molecules"},{"issue":"1","key":"10.1016\/j.tranon.2026.102978_bib0008","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1186\/s12943-024-02135-3","article-title":"Chinese herbal medicine for the treatment of intestinal cancer: preclinical studies and potential clinical applications","volume":"23","author":"Zhang","year":"2024","journal-title":"Mol. Cancer"},{"issue":"3","key":"10.1016\/j.tranon.2026.102978_bib0009","doi-asserted-by":"crossref","first-page":"989","DOI":"10.7150\/ijbs.105086","article-title":"Traditional Chinese medicine for Viral pneumonia therapy: pharmacological basis and mechanistic insights","volume":"21","author":"Bai","year":"2025","journal-title":"Int. J. Biol. Sci."},{"issue":"12","key":"10.1016\/j.tranon.2026.102978_bib0010","doi-asserted-by":"crossref","first-page":"455","DOI":"10.3390\/ph13120455","article-title":"Exploring herbal medicine use during palliative cancer care: the integrative physician as a facilitator of pharmacist-patient-oncologist communication","volume":"13","author":"Samuels","year":"2020","journal-title":"Pharmaceuticals"},{"key":"10.1016\/j.tranon.2026.102978_bib0011","doi-asserted-by":"crossref","DOI":"10.3389\/fnut.2022.887992","article-title":"Chemical comparison of monk fruit products processed by different drying methods using high-performance thin-layer chromatography combined with chemometric analysis","volume":"9","author":"Hong","year":"2022","journal-title":"Front. Nutr."},{"issue":"1","key":"10.1016\/j.tranon.2026.102978_bib0012","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1016\/S0304-3835(03)00285-4","article-title":"Anticarcinogenic activity of natural sweeteners, cucurbitane glycosides, from Momordica grosvenori","volume":"198","author":"Takasaki","year":"2003","journal-title":"Cancer Lett."},{"issue":"7","key":"10.1016\/j.tranon.2026.102978_bib0013","doi-asserted-by":"crossref","first-page":"548","DOI":"10.1080\/09637480701336360","article-title":"The antioxidant activities of natural sweeteners, mogrosides, from fruits of Siraitia grosvenori","volume":"58","author":"Chen","year":"2007","journal-title":"Int. J. Food Sci. Nutr."},{"issue":"12","key":"10.1016\/j.tranon.2026.102978_bib0014","doi-asserted-by":"crossref","first-page":"2084","DOI":"10.1038\/s41556-024-01550-4","article-title":"Chromatin remodelling in damaged intestinal crypts orchestrates redundant TGF\u03b2 and hippo signalling to drive regeneration","volume":"26","author":"Fink","year":"2024","journal-title":"Nat. Cell Biol."},{"issue":"4","key":"10.1016\/j.tranon.2026.102978_bib0015","doi-asserted-by":"crossref","DOI":"10.1016\/j.jbc.2024.107208","article-title":"Upregulation of CYR61 by TGF-\u03b2 and YAP signaling exerts a counter-suppression of hepatocellular carcinoma","volume":"300","author":"Zhang","year":"2024","journal-title":"J. Biol. Chem."},{"issue":"13","key":"10.1016\/j.tranon.2026.102978_bib0016","doi-asserted-by":"crossref","first-page":"4259","DOI":"10.7150\/ijbs.85986","article-title":"Coculture of cancer cells with platelets increases their survival and metastasis by activating the TGF\u03b2\/Smad\/PAI-1 and PI3K\/AKT pathways","volume":"19","author":"Tong","year":"2023","journal-title":"Int. J. Biol. Sci."},{"issue":"11","key":"10.1016\/j.tranon.2026.102978_bib0017","doi-asserted-by":"crossref","first-page":"3052","DOI":"10.1038\/s41418-021-00801-3","article-title":"RGS5-TGF\u03b2-Smad2\/3 axis switches pro- to anti-apoptotic signaling in tumor-residing pericytes, assisting tumor growth","volume":"28","author":"Dasgupta","year":"2021","journal-title":"Cell Death. Differ."},{"issue":"4","key":"10.1016\/j.tranon.2026.102978_bib0018","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1002\/mco2.70148","article-title":"Transforming growth factor Beta2 promotes migration and inhibits the proliferation of gastric cancer cells by regulating the pSmad2\/3-NDRG1 signaling pathway","volume":"6","author":"He","year":"2025","journal-title":"MedComm"},{"issue":"15","key":"10.1016\/j.tranon.2026.102978_bib0019","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1167\/iovs.64.15.12","article-title":"Lanosterol synthase prevents EMT during lens epithelial fibrosis via regulating SREBP1","volume":"64","author":"Ma","year":"2023","journal-title":"Invest. Ophthalmol. Visual Sci."},{"issue":"9","key":"10.1016\/j.tranon.2026.102978_bib0020","first-page":"457","article-title":"The Smad transcriptional corepressor TGIF recruits mSin3","volume":"12","author":"Wotton","year":"2001","journal-title":"Cell Growth Differ."},{"issue":"1","key":"10.1016\/j.tranon.2026.102978_bib0021","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1038\/s41392-024-01812-5","article-title":"c-myc-driven glycolysis polarizes functional regulatory B cells that trigger pathogenic inflammatory responses","volume":"9","author":"Wang","year":"2024","journal-title":"Signal Transduct. Tar."},{"issue":"1","key":"10.1016\/j.tranon.2026.102978_bib0022","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1038\/s41419-025-07645-6","article-title":"TACC3 enhances glycolysis in bladder cancer cells through inducing acetylation of c-myc","volume":"16","author":"Lin","year":"2025","journal-title":"Cell Death. Dis."},{"issue":"7","key":"10.1016\/j.tranon.2026.102978_bib0023","doi-asserted-by":"crossref","first-page":"1259","DOI":"10.1038\/s41418-025-01479-7","article-title":"The histone modifier KAT2A presents a selective target in a subset of well-differentiated microsatellite-stable colorectal cancers","volume":"32","author":"Kufrin","year":"2025","journal-title":"Cell Death. Differ."},{"issue":"34","key":"10.1016\/j.tranon.2026.102978_bib0024","doi-asserted-by":"crossref","DOI":"10.1002\/advs.202404628","article-title":"CircCFL1 Promotes TNBC stemness and immunoescape via deacetylation-mediated c-Myc deubiquitylation to facilitate mutant TP53 transcription","volume":"11","author":"Wang","year":"2024","journal-title":"Adv. Sci."},{"key":"10.1016\/j.tranon.2026.102978_bib0025","doi-asserted-by":"crossref","DOI":"10.1016\/j.biopha.2023.114926","article-title":"Pathologic HDAC1\/c-Myc signaling axis is responsible for angiotensinogen transcription and hypertension induced by high-fat diet","volume":"164","author":"Youn","year":"2023","journal-title":"Biomed. Pharmacother."},{"issue":"9","key":"10.1016\/j.tranon.2026.102978_bib0026","doi-asserted-by":"crossref","first-page":"1434","DOI":"10.1038\/s41556-024-01429-4","article-title":"Mitochondria and cell death","volume":"26","author":"Glover","year":"2024","journal-title":"Nat. Cell Biol."},{"issue":"10","key":"10.1016\/j.tranon.2026.102978_bib0027","doi-asserted-by":"crossref","first-page":"732","DOI":"10.1038\/s41580-023-00629-4","article-title":"Mechanisms of BCL-2 family proteins in mitochondrial apoptosis","volume":"24","author":"Czabotar","year":"2023","journal-title":"Nat. Rev. Mol. Cell Biol."},{"issue":"1","key":"10.1016\/j.tranon.2026.102978_bib0028","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1038\/cdd.2017.186","article-title":"BCL-2 family proteins: changing partners in the dance towards death","volume":"25","author":"Kale","year":"2018","journal-title":"Cell Death. Differ."},{"issue":"3","key":"10.1016\/j.tranon.2026.102978_bib0029","doi-asserted-by":"crossref","first-page":"206","DOI":"10.1016\/j.tips.2021.11.001","article-title":"Physiological and pharmacological modulation of BAX","volume":"43","author":"Spitz","year":"2022","journal-title":"Trends. Pharmacol. Sci."},{"issue":"1","key":"10.1016\/j.tranon.2026.102978_bib0030","first-page":"18","article-title":"Apatinib triggers autophagic and apoptotic cell death via VEGFR2\/STAT3\/PD-L1 and ROS\/Nrf2\/p62 signaling in lung cancer","volume":"40","author":"Xie","year":"2021","journal-title":"J. Exp. Clin. Cancer Res."},{"key":"10.1016\/j.tranon.2026.102978_bib0031","doi-asserted-by":"crossref","DOI":"10.1016\/j.neo.2026.101298","article-title":"ESM1 drives cancer angiogenesis and bevacizumab resistance via trioleate synthesis","volume":"75","author":"Chen","year":"2026","journal-title":"Neoplasia"}],"container-title":["Translational Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1936523326003141?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1936523326003141?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,10,11]],"date-time":"2026-10-11T07:29:03Z","timestamp":1791703743000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1936523326003141"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,11]]},"references-count":31,"alternative-id":["S1936523326003141"],"URL":"https:\/\/doi.org\/10.1016\/j.tranon.2026.102978","relation":{},"ISSN":["1936-5233"],"issn-type":[{"value":"1936-5233","type":"print"}],"subject":[],"published":{"date-parts":[[2026,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"11-Oxo-mogroside V attenuates lung adenocarcinoma progression by disrupting metabolic homeostasis and suppressing TGF\u03b22\/Myc-dependent oncogenic signaling","name":"articletitle","label":"Article Title"},{"value":"Translational Oncology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.tranon.2026.102978","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Authors. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}],"article-number":"102978"}}